Company Overview - Pharmaffiliates

Company Overview

2023
  • "Business Leadership of the Year Award-2023" presented to Dr. A.K. Sabharwal by the National Achievers Recognition Forum (NARF), India.
2022
  • Pharmaffiliates was recognized as one of the Top 100 SMEs for the third consecutive time.
  • In August 2022, recognized as 'Iconic Brand of the Year' by Blossoms Media, Mumbai.
2021
  • Dr. Ashok Kumar Sabharwal received the award "Outstanding Scientist and Innovative Entrepreneur" from the Indian Institute of Material Management.
2019
  • Transition to ISO 17034 Certification (RC -1004)
  • Winner of the India SME 100 Awards at the SME Convention 2019.
2018
  • Pharmaffiliates celebrates 18 years as a leading pharmaceutical service provider worldwide.
2017
  • Certified with ISO Guide 34 (RC -1004).
2016
  • Opened a new R&D laboratory in Hyderabad, India.
2015
  • Approved and accepted by the USFDA.
  • Winner of the SKOCH Award for SMEs in India.
2014
  • Certified with ISO 17025 for analytical services.
2013
  • Introduction of new services in active pharmaceutical ingredient research.
2012
  • Expansion into European and American markets.
2011
  • Opening of a new laboratory with enhanced analytical capabilities.
2010
  • Certification to international quality standards.
2009
  • Establishment as a reliable partner for reference standards.
2008
  • Commencement of international supply chain partnerships.
2007
  • Opening of a new branch in South India.
2006
  • Strengthening the team with experienced scientists.
2005
  • First award for quality and innovation.
2004
  • Launch of proprietary reference standards.
2003
  • Expansion of analytical instrumentation.
2002
  • Involvement in government-funded pharmaceutical projects.
2001
  • Founding of Pharmaffiliates under the leadership of Dr. A.K. Sabharwal.
CPHI INDIA- 28, 30 November